[Dosage problems in initial thyreostatic therapy of diffuse hyperthyreosis with methylmercaptoimidazole].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D013956:Antithyroid Agents / Q000008:administration & dosage*; D001481:Basal Metabolism; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy* / Q000378:metabolism; D007093:Imidazoles / Q000008:administration & dosage*; D007455:Iodine / Q000097:blood; D007854:Lead; D008713:Methimazole / Q000008:administration & dosage* / Q000627:therapeutic use; D008875:Middle Aged; D011868:Radioisotopes; D013960:Thyroid Function Tests
D013956:Antithyroid Agents; D007093:Imidazoles; D011868:Radioisotopes; D007854:Lead; D008713:Methimazole; D007455:Iodine
Dosierungsprobleme bei thyreostatischer Initialbehandlung der diffusen Hyperthyreose mit Methylmercaptoimidazol.